These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32544303

  • 41. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment.
    Tan DHS, Rana J, Tengra Z, Hart TA, Wilton J, Bayoumi AM.
    Sci Rep; 2021 Nov 15; 11(1):22252. PubMed ID: 34782691
    [Abstract] [Full Text] [Related]

  • 42. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
    Dean LT, Predmore Z, Skinner A, Napoleon S, Chan PA, Raifman J.
    AIDS Behav; 2023 Aug 15; 27(8):2606-2616. PubMed ID: 36670210
    [Abstract] [Full Text] [Related]

  • 43. Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine.
    Dubov A, Fraenkel L, Yorick R, Ogunbajo A, Altice FL.
    AIDS Behav; 2018 Apr 15; 22(4):1100-1112. PubMed ID: 29214409
    [Abstract] [Full Text] [Related]

  • 44. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
    Reyniers T, Fiorentino M, Babo SAY, Ouedraogo M, Kanta I, Agbegnigan LE, Rojas D, Anoma C, Dah TTE, Mensah E, Keita BD, Spire B, Vuylsteke B, Laurent C.
    AIDS Patient Care STDS; 2023 Oct 15; 37(10):480-488. PubMed ID: 37862074
    [Abstract] [Full Text] [Related]

  • 45. "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa.
    Fynn L, Gill K, Wallace M, Atujuna M, Duyver M, Ngcobo P, Spiegel H, Rinehart A, Hosek S, Bekker LG.
    BMC Public Health; 2023 Nov 02; 23(1):2143. PubMed ID: 37919697
    [Abstract] [Full Text] [Related]

  • 46. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.
    Greene GJ, Swann G, Fought AJ, Carballo-Diéguez A, Hope TJ, Kiser PF, Mustanski B, D'Aquila RT.
    AIDS Behav; 2017 May 02; 21(5):1336-1349. PubMed ID: 27770215
    [Abstract] [Full Text] [Related]

  • 47. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.
    Wu HJ, Wen-Wei Ku S, Chang HH, Li CW, Ko NY, Strong C.
    J Int AIDS Soc; 2021 May 02; 24(5):e25733. PubMed ID: 34018330
    [Abstract] [Full Text] [Related]

  • 48. Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.
    Chakrapani V, Newman PA, Cameron M, Shunmugam M, Roungprakhon S, Rawat S, Baruah D, Nelson R, Tepjan S, Scarpa R.
    AIDS Behav; 2021 Oct 02; 25(10):3074-3084. PubMed ID: 33818643
    [Abstract] [Full Text] [Related]

  • 49. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts.
    Shamu S, Shamu P, Khupakonke S, Farirai T, Chidarikire T, Guloba G, Nkhwashu N.
    Glob Health Action; 2021 Jan 01; 14(1):1886455. PubMed ID: 33606603
    [Abstract] [Full Text] [Related]

  • 50. Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men.
    Biello KB, Valente PK, da Silva DT, Lin W, Drab R, Hightow-Weidman L, Mayer KH, Bauermeister JA, iTech TeamDepartments of Behavioral & Social Sciences and Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA..
    J Int AIDS Soc; 2023 Jul 01; 26 Suppl 2(Suppl 2):e26096. PubMed ID: 37439061
    [Abstract] [Full Text] [Related]

  • 51. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
    Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP.
    Lancet HIV; 2018 Sep 01; 5(9):e498-e505. PubMed ID: 29908917
    [Abstract] [Full Text] [Related]

  • 52. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY, Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Terris-Prestholt F.
    BMC Public Health; 2019 Jul 24; 19(1):996. PubMed ID: 31340785
    [Abstract] [Full Text] [Related]

  • 53. Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.
    Lancaster KE, Lungu T, Bula A, Shea JM, Shoben A, Hosseinipour MC, Kohler RE, Hoffman IF, Go VF, Golin CE, Wheeler SB, Miller WC.
    AIDS Behav; 2020 May 24; 24(5):1294-1303. PubMed ID: 31720955
    [Abstract] [Full Text] [Related]

  • 54. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H, Zhang Y, Mei Z, Jia Y, Leuba SI, Zhang J, Chu Z, Ding H, Jiang Y, Geng W, Shang H, Xu J.
    BMC Infect Dis; 2019 Aug 15; 19(1):721. PubMed ID: 31416439
    [Abstract] [Full Text] [Related]

  • 55. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C, Diabaté S, Mondor M, Hessou S, Guédou FA, Béhanzin L, Batona G, Gning NN, Zannou DM, Alary M.
    BMC Public Health; 2020 Aug 20; 20(1):1267. PubMed ID: 32819335
    [Abstract] [Full Text] [Related]

  • 56. A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035.
    Bauermeister J, Lin W, Tingler R, Liu A, Chariyalertsak S, Hoesley C, Gonzales P, Ho K, Kayange N, Phillips TP, Johnson S, Brown E, Zemanek J, Jacobson CE, Doncel GF, Piper J, MTN-035 Protocol Team for the Microbicide Trials Network.
    J Int AIDS Soc; 2024 Mar 20; 27(3):e26219. PubMed ID: 38494656
    [Abstract] [Full Text] [Related]

  • 57. Prepared for PrEP: preferences for HIV pre-exposure prophylaxis among Chinese men who have sex with men in an online national survey.
    Huang W, Wu D, Ong JJ, Smith MK, Pan S, Yang F, Fu H, Tang W, Tucker JD.
    BMC Infect Dis; 2019 Dec 16; 19(1):1057. PubMed ID: 31842772
    [Abstract] [Full Text] [Related]

  • 58. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
    Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, Pidwell T, Mendel E, Fynn L, Jones K, Wiesner L, Slack C, Strode A, Spiegel H, Hosek S, Rooney J, Gray G, Bekker LG.
    Lancet Child Adolesc Health; 2020 Dec 16; 4(12):875-883. PubMed ID: 33222803
    [Abstract] [Full Text] [Related]

  • 59. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, Kenyon C, Wouters K, Laga M.
    J Int AIDS Soc; 2019 Oct 16; 22(10):e25407. PubMed ID: 31663257
    [Abstract] [Full Text] [Related]

  • 60. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
    Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie EE, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O'Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA, Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group.
    Lancet HIV; 2018 Nov 16; 5(11):e629-e637. PubMed ID: 30343026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.